Yoshida M, Noguchi J, Ikadai H, Takahashi M, Nagase S
Imamichi Institute for Animal Reproduction, Ibaraki, Japan.
J Clin Invest. 1993 Mar;91(3):1099-104. doi: 10.1172/JCI116268.
A rat colony with mucopolysaccharidosis VI was established and the clinical, pathological, and biochemical features were characterized. Affected rats had facial dysmorphia, dysostosis multiplex, and increased urinary excretion of glucosaminoglycans (GAGs). Ultrastructural studies revealed storage of GAGs throughout the reticuloendothelial cells, cartilage, and other connective tissues, but no deposition was observed in the nervous system. Biochemical analyses demonstrated that the excreted GAG was dermatan sulfate and the activity of hepatic arylsulfatase B was < 5% of the normal mean value. Pedigree analysis showed that the phenotype was inherited as an autosomal recessive single trait. The availability of a rat model of human mucopolysaccharidosis VI should permit the development and evaluation of various strategies to treat the human disease.
建立了患有黏多糖贮积症VI型的大鼠群体,并对其临床、病理和生化特征进行了表征。患病大鼠有面部畸形、多发性骨发育异常以及尿中氨基葡聚糖(GAGs)排泄增加。超微结构研究显示GAGs在整个网状内皮细胞、软骨和其他结缔组织中蓄积,但在神经系统中未观察到沉积。生化分析表明,排泄出的GAG是硫酸皮肤素,肝芳基硫酸酯酶B的活性<正常平均值的5%。系谱分析表明,该表型作为常染色体隐性单性状遗传。人类黏多糖贮积症VI型大鼠模型的可得性应有助于开发和评估治疗人类疾病的各种策略。